Alpha-Defensin and Synovial Proteins to Improve Detection of Pediatric Septic Arthritis

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeUp to 17
SponsorHospital for Special Surgery, New York

About this trial

Differentiating between septic arthritis and other causes of joint inflammation in pediatric patients is challenging and of the utmost importance because septic arthritis requires surgical debridement as part of the treatment regimen. The current gold standard to diagnose septic arthritis in children is a positive synovial fluid culture; however, joint cultures may take several days to return. If a bacterial infection is present, it requires immediate surgical intervention in order to prevent lasting articular cartilage damage. Frequently surgeons must decide whether to surgically debride a joint before culture results are available. There is no single lab test or clinical feature that reliably indicates bacterial infection over other causes of joint inflammation. The alpha-defensin assay has shown high sensitivity and specificity for joint infection in other studies.The purpose of this study is to determine the sensitivity and specificity of several synovial biomarkers for diagnosing pediatric septic arthritis.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Synovial fluid is obtained to assess for infection or inflammatory/rheumatologic disease (all medium and large joints will be included: hip, knee, ankle, shoulder, subtalar, elbow, and wrist joints)

Patients with recent antibiotic exposure are eligible to participate but will be analyzed separately

Patients undergoing a procedure unrelated to infection (the procedure may be arthroscopy, or an open or percutaneous bony or soft tissue procedure)

Disqualifiers

Family declines to participate/consent

Patients with a major joint trauma (such as a documented ligament tear or fracture) within the past 8 weeks are not eligible to have that joint aspirated, but could have another joint aspirated

A history of recent infection (within the past 3 months)

Received antibiotics in the past 7 days

Trial design

Design model

Parallel

Treatments tested in this trial

  • Synovial Alpha-defensin assay

    Diagnostic test

    One of the synovial fluid (joint fluid) tests that will be performed by the outside lab, CD Diagnostics.

  • Synovial Neutrophil elastase assay

    Diagnostic test

    One of the synovial fluid (joint fluid) tests that will be performed by the outside lab, CD Diagnostics.

  • Synovial lactate assay

    Diagnostic test

    Synovial Fluid (joint fluid) will be sent out to CD Diagnostics for this test.

  • Synovial C-reactive Protein (CRP)

    Diagnostic test

    One of the synovial fluid (joint fluid) tests that will be performed by the outside lab, CD Diagnostics.

  • Synovial Staphylococcus spp antigen panel

    Diagnostic test

    One of the synovial fluid (joint fluid) tests that will be performed by the outside lab, CD Diagnostics.

  • Synovial Candida spp antigen panel

    Diagnostic test

    One of the synovial fluid (joint fluid) tests that will be performed by the outside lab, CD Diagnostics.

  • Synovial Enterococcus faecalis assay

    Diagnostic test

    One of the synovial fluid (joint fluid) tests that will be performed by the outside lab, CD Diagnostics.

  • Synovial bacterial culture by BacT/Alert

    Diagnostic test

    The synovial fluid (joint fluid) sent to CD Diagnostics for testing will also be cultured to see if any organisms grow.

  • Synovial Cell count + differential (CBC)

    Diagnostic test

    One of the synovial fluid (joint fluid) tests that will be performed by the outside lab, CD Diagnostics.

  • Synovial Gram Stain

    Diagnostic test

    This will be performed by CD Diagnostics if any organisms are present in the synovial fluid.

  • Synovial Leukocyte Esterase Test Strips

    Diagnostic test

    These test strips will be tested at the hospital where the patient is being seen, a few drops of synovial fluid will be used on the strip.

  • Synovial PCR for Kingella kingae

    Diagnostic test

    In participants \< 8 years old, a sample of synovial fluid will be tested for Kingella kingae using PCR.

  • Serum Cell count + differential (CBC)

    Diagnostic test

    A blood test performed at the hospital.

  • Serum erythrocyte sedimentation rate (ESR)

    Diagnostic test

    A blood test performed at the hospital.

  • Serum C-reactive Protein (CRP)

    Diagnostic test

    A blood test performed at the hospital.

  • Serum D-dimer

    Diagnostic test

    A blood test performed at the hospital.

  • Serum Procalcitonin

    Diagnostic test

    A blood test performed at the hospital.

  • Blood Cultures

    Diagnostic test

    Blood will be cultured at the hospital to see if any organisms grow.

  • Optional blood testing per standard of care (ASO, anti-strep, ANA, anti-DS-DNA, HLA-B27, RF, Lyme and other inflammatory/ rheumatologic markers )

    Diagnostic test

    In patients with suspected inflammation/infection, there are other blood tests which may be standard of care and used for diagnosis.

Treatment groups

442 Participants
are divided into 2 treatment groups
Group A: Inflamed/Infected JointExperimental treatment 19 interventions
Group B: Normative ControlActive comparator 19 interventions

Trial outcomes

Primary outcomes

1

Sensitivity and specificity of experimental tests

Sensitivity and specificity have been selected as these are standard outcome tests when determining the utility of a diagnostic test.

Time frame
Interim analysis at 2 years of study recruitment

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Hospital for Special Surgery, New York

Lead sponsor

Pediatric Orthopaedic Society of North America

Collaborator

Children's Healthcare of Atlanta

Collaborator

Campbell Clinic

Collaborator

CD Diagnostics

Collaborator